Revealed: 2 Cheap Cannabis Stocks in September

Namaste Technologies Inc. (TSXV:N) and Canopy Growth Corp (TSX:WEED)(NYSE:CGC) both look like bargain picks ahead of edible legalization.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Cannabis stocks have been in a rut in the summer of 2019. Even during its best stretches, this sector has been volatile. Investors who are on the hunt for growth should be looking for discounts in the cannabis space in early September. Today, I want to look at two cannabis stocks that still have explosive potential.

In early August, I’d discussed why Namaste Technologies (TSXV:N) looked like a bargain. The stock was trading close to 52-week lows, which coincided with a rout in the broader sector. The company had released a positive second-quarter report in July and made a promising purchase agreement with an Alberta-based chocolate maker. Cannabis edibles are set for legalization next month.

Namaste stock has climbed 35% over the past month. It has enjoyed a big jump in early September, as investors are again warming up to it after a corporate restructuring brought on a sharp correction. E-commerce has been a huge disruptor in the retail space. Namaste operates as many as 30 different websites across 20 countries. It possesses a user base of 1.5 million.

Canada has had an especially frustrating brick-and-mortar rollout, making the e-commerce side a much more attractive stream right now. Namaste aims to establish itself as the Amazon of cannabis. This is a lofty goal as the industry is still very young, but Namaste has carved out a global presence very early in the game.

Shares of Namaste are still trading at the low end of its 52-week range. The stock has shot up into technically overbought territory due to its September rebound, but this should not scare off investors looking long term.

Canopy Growth (TSX:WEED)(NYSE:CGC) stock has enjoyed a marginal rebound in September, but shares have still plunged 36% over the last three months. It has made its way out of technically oversold territory, but the stock is still trading at the low end of its 52-week range. This stock is a nice complement to the micro-cap Namaste in your portfolio.

The largest cannabis company on the TSX has a flurry of products that will be launching in December. This could be one of the first big boosts Canopy receives from its partnership with Constellation Brands. Edibles are set to be big business in the cannabis space right away, and Canopy is ready to unveil many offerings including chocolate, vape pens, and cannabis-infused beverages.

There are also positive signs of movement for recreational cannabis south of the border. President Trump was typically mealy-mouthed when confronted with the prospect of federal legalization, but there is growing pressure from key voices in the Republican party to take a firmer stance. Canopy has positioned itself to enter the market quickly after its contingent agreement with U.S.-based Acreage Holdings, which is backed by former Republican Speaker of the House John Boehner.

Investors can expect to see its second-quarter results in November. I like Canopy at its current price ahead of edibles legalization.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. David Gardner owns shares of Amazon. The Motley Fool owns shares of Amazon.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »